All Stories

  1. SNED1 fibrillar assembly in the extracellular matrix requires fibronectin and collagen I
  2. SNED1 modulates ECM architecture and cell proliferation via its LDV integrin-binding motif
  3. Data from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
  4. Figure 1 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
  5. Figure 2 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
  6. Figure 3 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
  7. Figure 4 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
  8. Figure 5 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
  9. Supplementary Figure 1 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
  10. Supplementary Figure 2 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
  11. Supplementary Figure 3 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
  12. Supplementary Figure 4 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
  13. Supplementary Table 1 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
  14. Supplementary Table 2 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
  15. Supplementary Table 3 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
  16. Table 1 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
  17. Table 2 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
  18. Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
  19. Proteomic Data Processing and Matrisome Annotation of Human Placenta LC-MS/MS Data v1
  20. Placental Matrisome Proteomic Analysis by LC-MS/MS v1
  21. In Memoriam: Richard O. Hynes (1944–2026)
  22. MatriSpace: Identification and visualization of spatially resolved ECM gene expression patterns in health and disease
  23. SNED1 fibrillar assembly in the extracellular matrix requires fibronectin and collagen I
  24. SNED1 modulates ECM architecture and cell proliferation via LDV-binding integrins
  25. Comparative proteomic analysis of the ECM composition of the human omentum and mesentery, the main sites of ovarian cancer metastasis
  26. A guide to building the matrisome interactome: from computational predictions to experimental validation
  27. Fibronectin composition and transglutaminase 2 cross-linking cooperatively regulate ovarian cancer cell adhesion in ECM-mimetic constructs
  28. In-depth proteomic profiling of the extracellular matrix of pancreatic ductal adenocarcinomas identifies signatures correlating with lymphocyte infiltration
  29. Comparative proteomic analysis of the ECM composition of the human omentum and mesentery, the main sites of ovarian cancer metastasis
  30. MatriCom, a single-cell RNA-sequencing data mining tool to infer cell–extracellular matrix interactions
  31. Fibronectin Composition and Transglutaminase 2 Cross-linking Cooperatively Regulate Ovarian Cancer Cell Adhesion in ECM-Mimetic Constructs
  32. Time-lapse tryptic digestion: a proteomic approach to improve sequence coverage of extracellular matrix proteins
  33. The novel ECM protein SNED1 mediates cell adhesion via the RGD-binding integrins α5β1 and αvβ3
  34. MatriCom: a scRNA-Seq data mining tool to infer ECM-ECM and cell-ECM communication systems
  35. MatrixDB 2024: an increased coverage of extracellular matrix interactions, a new Network Explorer and a new web interface
  36. Proteomic insights into the extracellular matrix: a focus on proteoforms and their implications in health and disease
  37. Mechanisms of assembly and remodelling of the extracellular matrix
  38. The novel ECM protein SNED1 mediates cell adhesion via the RGD-binding integrins α5β1 and αvβ3
  39. Extracellular matrix dynamics: A key regulator of cell migration across length-scales and systems
  40. Matrisome AnalyzeR – a suite of tools to annotate and quantify ECM molecules in big datasets across organisms
  41. Desalting of Peptides to Prepare for Mass Spectrometry Analysis v2
  42. Matrisome AnalyzeR: A suite of tools to annotate and quantify ECM molecules in big datasets across organisms
  43. Ten Years of Extracellular Matrix Proteomics: Accomplishments, Challenges, and Future Perspectives
  44. Data from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  45. Data from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  46. GSEA gene sets from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  47. Ingenuity Pathway Analysis from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  48. MS data from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  49. Supplementary Figures from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  50. GSEA gene sets from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  51. Marker selection from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  52. Supplementary Tables from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  53. Ingenuity Pathway Analysis from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  54. Supplementary Figures from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  55. MS data from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  56. Supplementary Tables from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  57. Marker selection from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  58. Compartmental Protein Extraction to Achieve Enrichment of Extracellular Matrix (ECM) Proteins v1
  59. Reduced SPAG17 Expression in Systemic Sclerosis Triggers Myofibroblast Transition and Drives Fibrosis
  60. Beyond the matrisome: New frontiers in ECM research
  61. MatrisomeDB 2.0: 2023 updates to the ECM-protein knowledge database
  62. Systematic Analysis of Actively Transcribed Core Matrisome Genes Across Tissues and Cell Phenotypes
  63. New Views of Old Proteins: Clarifying the Enigmatic Proteome
  64. Time-lapsed proteomics reveals a role for the novel protein, SNED1, in modulating ECM composition and protein folding
  65. The matrix in focus: new directions in extracellular matrix research from the 2021 ASMB hybrid meeting
  66. A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy
  67. Multi-modal Profiling of the Extracellular Matrix of Human Fallopian Tubes and Serous Tubal Intraepithelial Carcinomas
  68. Computational and experimental characterization of the novel ECM glycoprotein SNED1 and prediction of its interactome
  69. The Burden of Post-Translational Modification (PTM)—Disrupting Mutations in the Tumor Matrisome
  70. Knockout of the gene encoding the extracellular matrix protein SNED1 results in early neonatal lethality and craniofacial malformations
  71. Spatial-omics: Novel approaches to probe cell heterogeneity and extracellular matrix biology
  72. The liver matrisome – looking beyond collagens
  73. Computational and experimental characterization of the novel ECM glycoprotein SNED1 and prediction of its interactome
  74. Pan-Cancer Analysis of the Genomic Alterations and Mutations of the Matrisome
  75. Proteomic pipeline to identify age-related compositional and structural changes of the human dentin extracellular matrix
  76. Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  77. The Extracellular Matrix Goes -Omics: Resources and Tools
  78. The Matrisome of Model Organisms: From In-Silico Prediction to Big-Data Annotation
  79. In-silico definition of the Drosophila melanogaster matrisome
  80. MatrisomeDB: the ECM-protein knowledge database
  81. Exploring the extracellular matrix in health and disease using proteomics
  82. The in-silico characterization of the Caenorhabditis elegans matrisome and proposal of a novel collagen classification
  83. MatrixDB: integration of new data with a focus on glycosaminoglycan interactions
  84. Knockout of the gene encoding the extracellular matrix protein Sned1 results in craniofacial malformations and early neonatal lethality
  85. The cancer matrisome: From comprehensive characterization to biomarker discovery
  86. Extracellular matrix in lung development, homeostasis and disease
  87. The in-silico zebrafish matrisome: A new tool to study extracellular matrix gene and protein functions
  88. Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics
  89. Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival
  90. Proteomic characterization of human multiple myeloma bone marrow extracellular matrix
  91. Comprehensive proteomic characterization of stem cell-derived extracellular matrices
  92. Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression
  93. Lamellipodin promotes invasive 3D cancer cell migration via regulated interactions with Ena/VASP and SCAR/WAVE
  94. The extracellular matrix: Tools and insights for the “omics” era
  95. Enrichment of Extracellular Matrix Proteins from Tissues and Digestion into Peptides for Mass Spectrometry Analysis
  96. Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver
  97. Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters
  98. Towards definition of an ECM parts list: An advance on GO categories
  99. Abstract SY28-01: Multiple changes in tumor extracellular matrices
  100. Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells
  101. Ezrin regulates microvillus morphogenesis by promoting distinct activities of Eps8 proteins
  102. The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
  103. Overview of the Matrisome--An Inventory of Extracellular Matrix Constituents and Functions
  104. Emerging role for ERM proteins in cell adhesion and migration
  105. Abstract 2370: A novel Src/Ezrin pathway regulates local invasion and metastasis of breast
  106. Inhibition of endothelial cell chemotaxis toward FGF-2 by gefitinib associates with downregulation of Fes activity
  107. Ezrin is a target for oncogenic Kit mutants in murine erythroleukemia
  108. Spatial recruitment and activation of the Fes kinase by ezrin promotes HGF‐induced cell scattering